[Source: EarthTimes.org] – ImmuneRegen BioSciences, Inc. (“ImmuneRegen”), a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), today announced the execution of a Material Transfer Agreement (MTA) with Archimedes Development Limited (“Archimedes”), of the UK, an initial step to enable the companies to investigate possible synergies between their technology platforms.
For more information: ImmuneRegen BioSciences(R) Announces Collaboration With Archimedes Development Limited